GCL
BEAT

Glazer Capital LLC’s BioTelemetry, Inc. BEAT Stock Holding History

Glazer Capital LLC’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-308,600
Closed -$22.2M – 873
2020
Q4 		$22.2M Buy
+308,600
New +$16.2M 0.79% 34

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Glazer Capital LLC's BEAT Position: Q1 2021 in Review

Glazer Capital LLC sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 308,600 shares — an estimated $22.2M sold.

Glazer Capital LLC first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $22.2M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Glazer Capital LLC reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 308,600 BioTelemetry, Inc. shares in Q1 2021, an estimated $22.2M.
  • Glazer Capital LLC first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
  • Glazer Capital LLC's BioTelemetry, Inc. position peaked at $22.2M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Glazer Capital LLC's 13F filing for Q1 2021, filed 14 May 2021.